“Risk Assessment of QT-Prolonging Drug Combinations and Their Association with QTc Interval Prolongation Among Psychiatric Patients: A Prospective Observational Study” (2026) International Journal of Research in Pharmaceutical Sciences and Technology, 9(3). doi:10.33974/rveyrh87.